Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Odyssey Health (ODYY) Change in Receivables (2016 - 2024)

Odyssey Health has reported Change in Receivables over the past 4 years, most recently at -$10000.0 for Q1 2017.

  • For Q1 2017, Change in Receivables changed N/A year-over-year to -$10000.0; the TTM value through Oct 2017 reached -$10000.0, down 190.48%, while the annual FY2024 figure was -$253941.0, 182.45% down from the prior year.
  • Change in Receivables for Q1 2017 was -$10000.0 at Odyssey Health, down from -$7000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $30231.0 in Q1 2015 and troughed at -$47151.0 in Q2 2015.
  • A 4-year average of $150.29 and a median of -$4448.0 in 2016 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 147.72% in 2016 and fell as far as 147.72% in 2016.
  • Year by year, Change in Receivables stood at $16920.0 in 2014, then plummeted by 378.67% to -$47151.0 in 2015, then skyrocketed by 85.15% to -$7000.0 in 2016, then plummeted by 42.86% to -$10000.0 in 2017.
  • Business Quant data shows Change in Receivables for ODYY at -$10000.0 in Q1 2017, -$7000.0 in Q4 2016, and -$4448.0 in Q3 2016.